SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-19-029599
Filing Date
2019-06-04
Accepted
2019-06-04 09:01:21
Documents
14
Effectiveness Date
2019-06-04

Document Format Files

Seq Description Document Type Size
1 DEFA14A tv523017_defa14a.htm DEFA14A 33829
2 GRAPHIC image_001.jpg GRAPHIC 81776
3 GRAPHIC image_002.jpg GRAPHIC 226137
4 GRAPHIC image_003.jpg GRAPHIC 132797
5 GRAPHIC image_004.jpg GRAPHIC 69723
6 GRAPHIC image_005.jpg GRAPHIC 75587
7 GRAPHIC image_006.jpg GRAPHIC 81312
8 GRAPHIC image_007.jpg GRAPHIC 76425
9 GRAPHIC image_008.jpg GRAPHIC 118970
10 GRAPHIC image_009.jpg GRAPHIC 64000
11 GRAPHIC image_010.jpg GRAPHIC 83380
12 GRAPHIC image_011.jpg GRAPHIC 95986
13 GRAPHIC image_012.jpg GRAPHIC 78553
14 GRAPHIC image_013.jpg GRAPHIC 99258
  Complete submission text file 0001144204-19-029599.txt   1805098
Mailing Address 1600 BROADWAY SUITE 700 DENVER CO 80202
Business Address 1600 BROADWAY SUITE 700 DENVER CO 80202 720 697 5200
BioScrip, Inc. (Filer) CIK: 0001014739 (see all company filings)

IRS No.: 050489664 | State of Incorp.: CO | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-11993 | Film No.: 19875390
SIC: 8082 Services-Home Health Care Services